{
    "title": "Canadians hope $250 mln trial can revive failed Roche heart drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3116808/Canadians-hope-250-mln-trial-revive-failed-Roche-heart-drug.html",
    "date": "2015-06-09",
    "keywords": [
        "heart",
        "dalcetrapib",
        "roche",
        "mhi",
        "trial",
        "drug",
        "gmt",
        "june",
        "dalcor",
        "phase",
        "project",
        "protein",
        "industry",
        "disease",
        "world",
        "class",
        "cholesterol",
        "email",
        "ben",
        "hirschlerjune",
        "team",
        "profile",
        "ability",
        "cholesterolthe",
        "swiss",
        "drugmaker",
        "tuesday",
        "companion",
        "diagnostic",
        "use",
        "iii",
        "studydalcor",
        "collaboration",
        "institute",
        "profileroche",
        "development",
        "lack",
        "efficacy",
        "studythe",
        "failure",
        "blow",
        "confidence",
        "idea",
        "cetp",
        "way",
        "hdl",
        "setback",
        "reach",
        "future",
        "syndrome",
        "profilethe",
        "research",
        "indicating",
        "cardiovascular",
        "risk",
        "inhibitor",
        "point",
        "scale",
        "termination",
        "anacetrapib",
        "lillys",
        "finalstage",
        "ldl",
        "number",
        "population",
        "killer",
        "opening",
        "attention",
        "pcsk9",
        "amgen",
        "rival",
        "market",
        "david"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}